BVDV (Bovine Virus Diarrhea Virus) SMU-Z6/1a/SC/2016 isolate and application thereof
A technology of bovine viral diarrhea and SMU-Z6, which is applied in the field of bioengineering to achieve the effects of good immunogenicity, strong pertinence and broad market application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] The isolation and identification of embodiment 1 bovine viral diarrhea virus
[0032] 1.1 Isolation of bovine viral diarrhea virus
[0033] First observe the morbidity of the cattle herd, and the inventor collects a cattle feces sample initially diagnosed as diarrhea. Stool samples were diluted 1:5 with PBS (100 U / mL penicillin, 100 g / mL streptomycin). Centrifuge at 3000r / min for 10min, and the obtained supernatant is filtered and sterilized by a 0.22μm filter membrane to obtain a disease material treatment solution.
[0034] Inoculate the above-mentioned disease material treatment solution on a vigorously growing monolayer of MDBK cells on a 6-well culture plate, inoculate 0.5 mL per well, and set up negative control wells at 37°C with 5% CO 2 Incubate for 1 hour in the incubator, discard the inductive solution, add 2 mL of maintenance solution (DMEM with 1% fetal bovine serum), at 37°C containing 5% CO 2 Cultivate in an incubator, observe the cytopathic changes eve...
Embodiment 2B
[0052] The development of embodiment 2BVDV inactivated vaccine
[0053] 2.1 Virus reproduction
[0054] Take the MDBK monolayer cells in a good growth state, wash them twice with Hanks, inoculate the cell culture medium of the above-mentioned vaccine candidate strain SMU-Z6 / 1a / SC / 2016 with good immunogenicity into the MDBK cells, add 1% fetal bovine Serum in DMEM cell maintenance solution at 37°C with 5% CO 2 Cultivate in an incubator, and when the cytopathic rate is about 80%, harvest the virus culture medium, freeze and thaw 3 times, and centrifuge at 4°C at high speed to obtain the virus supernatant as the virus for the vaccine.
[0055] 2.2 Preparation of virus inactivated vaccine
[0056] The cell culture supernatant of the vaccine candidate strain SMU-Z6 / 1a / SC / 2016 with good immunogenicity above was fully mixed with β-propiolactone with a final concentration of 0.5%, and shaken at 37°C. Bed, inactivation treatment 6h. Two copies of the inactivated virus solution were...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com